我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
44
10 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1956
进行中（未招募）
2
4.5%
已完成
8
18.2%
Enrolling By Invitation
1
2.3%
尚未招募
7
15.9%
招募中
10
22.7%
Unknown
16
36.4%
暂无批准数据
- A comprehensive meta-analysis of 34 randomized controlled trials involving 2,976 participants has validated the efficacy of Si-Shen-Wan (SSW) in treating diarrhea-predominant irritable bowel syndrome. - The traditional Chinese medicine formula demonstrated significant improvements in multiple symptom scores including abdominal pain, diarrhea, abdominal distension, and loss of appetite in IBS-D patients. - Researchers from leading Chinese medical institutions employed trial sequential analysis to ensure robust findings, potentially offering a valuable alternative treatment for this common functional gastrointestinal disorder.
